PO.BCS01.15 · 生物信息与计算

标准化儿童体细胞癌症变异分类的大规模资源

A large-scale resource of standardized pediatric somatic cancer variant classifications

海报缩略图:标准化儿童体细胞癌症变异分类的大规模资源
编号 1508 展板 15 时间 4/20 09:00–12:00 区域 Section 6 主讲 Alex Wagner, PhD
分会场 Sequence Analysis
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Alex H. Wagner, Kori Kuzma, Kathleen M. Schieffer, Wesley Goar, Don Corsmeier, Michael McCarrick, Kathryn Perry, Jennifer Bowser, James Stevenson, Mohammad Marhabaie, Matthew Cannon, Liana Hernandez, Doug Depoorter, Hongtao Jia, Amy Everest, Jessica Howard, Swetha Ramadesikan, Vijayakumar Jayaraman, Ying-Chen C. Hou, Mariam T. Mathew, Marco L. Leung, Yassmine M. N. Akkari, Daniel Puthawala, Anastasia Bratulin, Ben Kelly, Elaine R. Mardis, Catherine E. Cottrell

Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH

摘要 Abstract

中文摘要
背景:我们解读儿童癌症基因组以确定靶向治疗策略的能力,受制于关于所检测到的体细胞突变临床意义的结构化知识有限这一瓶颈。临床基因组学实验室通常在临时存储系统(如电子表格、自定义数据库)中保存以往分类变异的内部记录,但存在显著的技术壁垒,妨碍此类知识在机构间的广泛传播。近期由全球基因组学与健康联盟(GA4GH)开发的基因组知识标准,通过一个用于传播基因组知识的共享社区框架,为消除这些壁垒奠定了基础。 方法与结果:我们采用这些GA4GH标准,产出了超过1,500条公开可用的体细胞变异分类记录。这些记录作为一家研究型医院常规儿童癌症基因组评估的一部分进行了整理,其中94%(1415/1504)是在美国国立癌症研究所儿童癌症数据倡议的分子特征描述计划(Molecular Characterization Initiative)下评估的。为广泛传播这些数据,我们扩展了开源的「ClinVar This!」社区软件,使其能够接收GA4GH标准化记录并提交至NIH的ClinVar知识库。因此,我们已将提交至ClinVar的体细胞癌症记录总数增加了一倍以上(此前所有其他社区提交合计为1,325条记录)。我们预计到2026年4月将再提交2,000条记录。为支持这一工作,我们开发了Variation Categorizer(VarCat)网络平台,以简化在儿童背景下临床变异分类中社区标准的结构化应用。该软件目前支持社区体细胞变异分类指南中关于临床意义(「AMP/ASCO/CAP指南」)和致癌性(「ClinGen/CGC/VICC指南」)的分类。VarCat是一款开源、经临床验证的网络工具,提供了一种精简机制,可将符合GA4GH标准的儿童体细胞癌症知识传播自动化,作为常规临床工作流程的一部分。 结论:这项工作展示了这些新型GA4GH标准如何使我们能够将体细胞癌症变异知识的传播作为常规临床操作的一部分。我们的展示将重点介绍VarCat平台的使用以及我们已公开提供的相关标准化变异分类数据。我们还将分享在应用这些标准以体现对社区指南进行细致调整用于临床变异解读方面的见解。最后,我们将就如何最佳地利用这些资源作为一种可扩展方法来解决临床环境中变异解读瓶颈,提供实用指导。
查看英文原文 English abstract
Background: Our ability to interpret pediatric cancer genomes to identify targeted therapeutic strategies is bottlenecked by limited structured knowledge about the clinical significance of detected somatic mutations. Clinical genomics laboratories routinely keep internal records of previously classified variants in ad hoc storage systems (e.g., spreadsheets, custom databases), but significant technical barriers exist that prevent the broad dissemination of such knowledge for use across institutions. Recently developed genomic knowledge standards from the Global Alliance for Genomics and Health (GA4GH) provide the foundation to remove these barriers through a shared community framework for disseminating genomic knowledge. Methods and Results: We implemented these GA4GH standards to produce over 1,500 publicly available somatic variant classification records. These were curated as part of routine pediatric cancer genome assessment in a research hospital setting, 94% (1415/1504) of which were assessed under the Molecular Characterization Initiative of the National Cancer Institute's Childhood Cancer Data Initiative. To broadly disseminate these data, we extended the open-source “ClinVar This!” community software to ingest GA4GH-standardized records for submission to the NIH ClinVar knowledgebase. As a result, we have more than doubled the total number of somatic cancer records submitted to ClinVar (previously 1,325 records across all other community submissions). We anticipate submitting an additional 2,000 records by April 2026. To support this effort, we developed the Variation Categorizer (VarCat) web platform to simplify the structured application of community standards for clinical variant classification in a pediatric setting. The software currently supports community somatic variant classification guidelines for clinical significance (the “AMP/ASCO/CAP guidelines”) and oncogenicity (the “ClinGen/CGC/VICC guidelines”). VarCat is an open-source, clinically validated web tool that provides a streamlined mechanism for automating GA4GH-compliant dissemination of pediatric somatic cancer knowledge as part of routine clinical workflows. Conclusions: This work demonstrates how these novel GA4GH standards enable us to disseminate somatic cancer variant knowledge as part of routine clinical operations. Our presentation will highlight the use of the VarCat platform and the associated standardized variant classification data we have made publicly available. We will also share insights from our applications of these standards to capture nuanced adaptation of community guidelines for clinical variant interpretation. We will conclude with practical guidance about how to best leverage these resources as a scalable approach to addressing the variant interpretation bottleneck in the clinical setting.
利益披露 Disclosure
A. H. Wagner, None.. K. Kuzma, None.. K. M. Schieffer, None.. W. Goar, None.. D. Corsmeier, None.. M. McCarrick, None.. K. Perry, None.. J. Bowser, None.. J. Stevenson, None.. M. Marhabaie, None.. M. Cannon, None.. L. Hernandez, None.. D. Depoorter, None.. H. Jia, None.. A. Everest, None.. J. Howard, None.. S. Ramadesikan, None.. V. Jayaraman, None.. Y. C. Hou, None.. M. T. Mathew, None.. M. L. Leung, None.. Y. M. N. Akkari, None.. D. Puthawala, None.. A. Bratulin, None.. B. Kelly, None.. E. R. Mardis, None.. C. E. Cottrell, None.

← 返回 AACR 2026 检索